By: Ralph Cotran
Scientists at Brien Holden Vision Institute (BHVI) are responsible for the creation of a another kind of contact lens that just recently received approval to be sold to retailers around the United States. On April 23rd, the newly updated lenses with an extended depth of focus (EDOF), were just approved by the Federal Drug Administration and the US Health Control. The product is expected to hit the US market very soon.
Brien Holden, professor and CEO of BHVI, believes that “this is an imperative venture forward in quality vision for presbyopes.” The contact lenses were designed by BHVI analyst, Dr Ravi Bakaraju, and are expected to help people who wear contact lenses to see better and much more clearly closeup and faraway, while diminishing the normal visuals of ghosting and haloes.
Dr Bakaraju was quoted that “many claims are made that multifocal lenses provide simultaneous vision at various visual distances but often this comes at the cost of reduced contrast, increased ghosting and compromised overall vision satisfaction.” A complete database also shows that our contact lenses will give an extraordinarily advantage the US advertise, and others. The contact lenses are derived from another product put forth by BHVI, Brien Holden Vision Pty Ltd, which will also be accessible toward the end of this year.
Holden explains that contact lenses represents a huge development towards the improvement of science, innovation and innovative work. Brien Holden Vision Institute will give a generous part of its benefits to store our work during a time when improvements in science need as much help as possible. BHVI is dedicated to correcting the disabilities of people who suffer with eye sight, and with more than 625 million people who are vision impaired this need becomes even more of a priority. Many of these patient do not have access to healthcare, nor do they have the resources to pay for tests and glasses, which is why these efforts are impertinent.